Reconfigurable Microfluidic Magnetic Valve Arrays: Towards a Radiotherapy-Compatible Spheroid Culture Platform for the Combinatorial Screening of Cancer Therapies.
Alexandre R BrunetFrédérique LabellePhilip WongThomas GervaisPublished in: Sensors (Basel, Switzerland) (2017)
We introduce here a microfluidic cell culture platform or spheroid culture chamber array (SCCA) that can synthesize, culture, and enable fluorescence imaging of 3D cell aggregates (typically spheroids) directly on-chip while specifying the flow of reagents in each chamber via the use of an array of passive magnetic valves. The SCCA valves demonstrated sufficient resistance to burst (above 100 mBar), including after receiving radiotherapy (RT) doses of up to 8 Gy combined with standard 37 °C incubation for up to 7 days, enabling the simultaneous synthesis of multiple spheroids from different cell lines on the same array. Our results suggest that SCCA would be an asset in drug discovery processes, seeking to identify combinatorial treatments.
Keyphrases
- high throughput
- single cell
- fluorescence imaging
- drug discovery
- aortic valve
- early stage
- aortic valve replacement
- locally advanced
- photodynamic therapy
- circulating tumor cells
- molecularly imprinted
- radiation therapy
- radiation induced
- papillary thyroid
- transcatheter aortic valve replacement
- aortic stenosis
- mental health
- high density
- mitral valve
- cell therapy
- high resolution
- stem cells
- squamous cell
- mesenchymal stem cells
- label free
- ejection fraction
- lymph node metastasis